A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients

Overview of attention for article published in BMC Cancer, February 2017

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 421 followers.

A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients. https://t.co/jxqglTH5Qv

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.